These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10886786)

  • 1. Differences in the ligand specificity between CD1d-restricted T cells with limited and diverse T-cell receptor repertoire.
    Makowska A; Kawano T; Taniguchi M; Cardell S
    Scand J Immunol; 2000 Jul; 52(1):71-9. PubMed ID: 10886786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells.
    Gui M; Li J; Wen LJ; Hardy RR; Hayakawa K
    J Immunol; 2001 Dec; 167(11):6239-46. PubMed ID: 11714786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments.
    Chiu YH; Jayawardena J; Weiss A; Lee D; Park SH; Dautry-Varsat A; Bendelac A
    J Exp Med; 1999 Jan; 189(1):103-10. PubMed ID: 9874567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families.
    Park SH; Weiss A; Benlagha K; Kyin T; Teyton L; Bendelac A
    J Exp Med; 2001 Apr; 193(8):893-904. PubMed ID: 11304550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
    J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
    Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Motoki K; Ueno H; Nakagawa R; Sato H; Kondo E; Koseki H; Taniguchi M
    Science; 1997 Nov; 278(5343):1626-9. PubMed ID: 9374463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.
    Wei DG; Curran SA; Savage PB; Teyton L; Bendelac A
    J Exp Med; 2006 May; 203(5):1197-207. PubMed ID: 16651387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
    Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
    J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.
    Brossay L; Chioda M; Burdin N; Koezuka Y; Casorati G; Dellabona P; Kronenberg M
    J Exp Med; 1998 Oct; 188(8):1521-8. PubMed ID: 9782129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses.
    Molano A; Park SH; Chiu YH; Nosseir S; Bendelac A; Tsuji M
    J Immunol; 2000 May; 164(10):5005-9. PubMed ID: 10799852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.
    Kita H; Naidenko OV; Kronenberg M; Ansari AA; Rogers P; He XS; Koning F; Mikayama T; Van De Water J; Coppel RL; Kaplan M; Gershwin ME
    Gastroenterology; 2002 Oct; 123(4):1031-43. PubMed ID: 12360465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.